Skip to main content

Intuitive Surgical income statement

  • ISRG · Nasdaq
  • Medical devices
  • Health Care Equipment
  • S&P 500
$443.59+0.84%Close 13 Nov 2026 · Market value $152.6B

Intuitive Surgical reported revenue of $10.1 billion for fiscal year 2025 (the twelve months to 31 Dec 2025), up 20.5% from fiscal 2024. Net income was $2.86 billion and diluted earnings per share $7.87.

From Intuitive Surgical's annual and quarterly reports, each period checked against accounting identities; a figure that does not pass is left blank. Fiscal years follow the company's calendar, the latest ending 31 Dec 2025. TTM is the last four reported quarters added up.

Annual

Intuitive Surgical income statement, annual
USDFY 2007FY 2008FY 2009FY 2010FY 2011FY 2012FY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Revenue$600.8M$874.9M$1.05B$1.41B$1.76B$2.18B$2.27B$2.13B$2.38B$2.70B$3.14B$3.72B$4.48B$4.36B$5.71B$6.22B$7.12B$8.35B$10.06B$11.58B
Revenue growth—+45.6%+20.3%+34.3%+24.4%+24.0%+4.0%−5.9%+11.9%+13.4%+16.0%+18.7%+20.3%−2.7%+31.0%+9.0%+14.5%+17.2%+20.5%—
Cost of revenue$186.5M$254.1M$301.1M$383.0M$483.5M$608.5M$670.9M$717.9M$806.5M$814.3M$936.2M$1.12B$1.37B$1.50B$1.75B$2.03B$2.39B$2.72B$3.42B$3.80B
Gross profit$414.3M$620.8M$751.1M$1.03B$1.27B$1.57B$1.59B$1.41B$1.58B$1.89B$2.20B$2.60B$3.11B$2.86B$3.96B$4.20B$4.73B$5.63B$6.64B$7.78B
Gross margin69.0%71.0%71.4%72.9%72.5%72.1%70.4%66.3%66.2%70.0%70.2%69.9%69.4%65.6%69.3%67.4%66.4%67.5%66.0%67.2%
Research and development$48.86M$79.40M$95.10M$116.0M$140.2M$170.0M$167.7M$178.0M$197.4M$239.6M$328.6M$418.1M$557.3M$595.1M$671.0M$879.0M$998.8M$1.15B$1.31B$1.49B
Selling, general and administrative$158.7M$230.6M$278.6M$358.8M$438.8M$522.2M$574.0M$691.0M$640.5M$703.6M$810.5M$986.6M$1.18B$1.22B$1.47B$1.74B$1.96B$2.14B$2.38B$2.55B
Operating expenses$207.5M$310.0M$373.7M$474.8M$579.0M$692.2M$741.7M$869.0M$837.9M$943.2M$1.14B$1.40B$1.74B$1.81B$2.14B$2.62B$2.96B$3.29B$3.70B$4.50B
Operating income$206.7M$310.8M$377.4M$555.2M$694.8M$878.1M$852.5M$544.8M$740.0M$949.7M$1.06B$1.20B$1.37B$1.05B$1.82B$1.58B$1.77B$2.35B$2.95B$3.28B
Operating margin34.4%35.5%35.9%39.3%39.5%40.3%37.6%25.6%31.0%35.1%33.9%32.2%30.7%24.1%31.9%25.3%24.8%28.1%29.3%28.4%
Other income and expense$30.49M$24.40M$18.70M$17.10M$14.90M$15.80M$18.40M$4.20M$18.50M$35.60M$41.90M$80.10M$127.7M$157.2M$69.30M$29.70M$192.1M$324.9M$365.9M$334.9M
Income before tax$237.2M$335.2M$396.1M$572.3M$709.7M$893.9M$870.9M$549.0M$758.5M$985.3M$1.10B$1.28B$1.50B$1.21B$1.89B$1.61B$1.96B$2.67B$3.31B$3.62B
Income tax expense$92.70M$130.9M$163.5M$190.5M$214.6M$237.3M$199.9M$130.2M$169.7M$247.0M$433.9M$154.5M$120.4M$140.2M$162.2M$262.4M$141.6M$336.3M$434.8M$645.9M
Effective tax rate39.1%39.1%41.3%33.3%30.2%26.5%23.0%23.7%22.4%25.1%39.3%12.1%8.0%11.6%8.6%16.3%7.2%12.6%13.1%17.8%
Net income$144.5M$204.3M$232.6M$381.8M$495.1M$656.6M$671.0M$418.8M$588.8M$738.3M$670.9M$1.13B$1.38B$1.06B$1.70B$1.32B$1.80B$2.32B$2.86B$2.96B
Net margin24.1%23.4%22.1%27.0%28.2%30.1%29.6%19.6%24.7%27.3%21.4%30.3%30.8%24.3%29.9%21.3%25.2%27.8%28.4%25.5%
EPS · diluted$0.41$0.57$0.66$1.05$1.37$1.78$1.86$1.23$1.73$2.09$1.92$3.16$3.85$2.94$4.66$3.65$5.03$6.42$7.87$8.28
Diluted weighted average shares351M359M353M363M362M370M361M339M341M354M349M356M358M361M366M362M357M362M363M357M
Basic weighted average shares340M350M345M353M353M358M353M332M334M345M335M341M346M351M356M356M351M355M357M353M
EBITDA$219.8M$335.9M$412.0M$595.6M$741.3M$935.9M$919.8M$619.2M$825.5M$1.04B$1.16B$1.32B$1.57B$1.33B$2.13B$1.94B$2.22B$2.85B$3.62B$4.12B
EBITDA margin36.6%38.4%39.2%42.2%42.2%43.0%40.6%29.0%34.6%38.4%36.9%35.4%35.2%30.4%37.3%31.2%31.2%34.1%36.0%35.6%
Depreciation & amortization$13.03M$25.10M$34.60M$40.40M$46.50M$57.80M$67.30M$74.40M$85.50M$88.90M$95.00M$120.1M$200.0M$276.2M$310.2M$365.8M$454.8M$499.7M$677.1M$837.5M
Stock-based compensation$36.29M$76.60M$97.00M$117.6M$136.4M$153.3M$168.9M$168.9M$167.9M$177.6M$209.1M$261.2M$335.8M$395.4M$449.2M$513.2M$592.8M$676.8M$788.2M$835.3M

Quarterly

Intuitive Surgical income statement, quarterly
USDQ4 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Revenue$1.93B$1.89B$2.01B$2.04B$2.41B$2.25B$2.44B$2.51B$2.87B$2.77B$2.89B$3.05B
Cost of revenue$650.9M$645.2M$637.2M$664.2M$771.3M$795.7M$822.1M$842.7M$961.9M$940.3M$931.9M$964.4M
Gross profit$1.28B$1.25B$1.37B$1.37B$1.64B$1.46B$1.62B$1.66B$1.90B$1.83B$1.96B$2.08B
Gross margin66.2%65.9%68.3%67.4%68.0%64.7%66.3%66.4%66.4%66.1%67.8%68.4%
Research and development$260.1M$284.5M$280.1M$286.0M$294.7M$316.2M$313.3M$329.4M$352.9M$361.9M$370.6M$408.3M
Selling, general and administrative$567.1M$491.5M$525.3M$510.6M$612.6M$563.4M$561.2M$573.3M$687.1M$613.3M$617.9M$633.4M
Operating expenses$827.2M$776.0M$805.4M$796.6M$907.3M$879.6M$874.5M$902.7M$1.04B$975.2M$988.5M$1.49B
Operating income$450.2M$469.4M$567.3M$577.3M$734.9M$578.1M$743.4M$759.7M$864.3M$855.3M$971.9M$592.6M
Operating margin23.3%24.8%28.2%28.3%30.4%25.7%30.5%30.3%30.2%30.9%33.6%19.4%
Other income and expense$65.70M$69.10M$87.20M$93.70M$74.90M$90.40M$88.70M$95.50M$91.30M$85.10M$82.70M$75.80M
Income before tax$515.9M$538.5M$654.5M$671.0M$809.8M$668.5M$832.1M$855.2M$955.6M$940.4M$1.05B$668.4M
Income tax expense−$94.80M−$8.90M$123.0M$100.4M$121.8M−$35.20M$167.9M$146.0M$156.1M$114.4M$231.4M$144.0M
Effective tax rate−18.4%−1.7%18.8%15.0%15.0%−5.3%20.2%17.1%16.3%12.2%21.9%21.5%
Net income$606.2M$544.9M$526.9M$565.1M$685.7M$698.4M$658.4M$704.4M$794.8M$821.5M$818.1M$522.8M
Net margin31.4%28.8%26.2%27.7%28.4%31.0%27.0%28.1%27.7%29.6%28.3%17.1%
EPS · diluted$1.69$1.51$1.46$1.56$1.88$1.92$1.81$1.95$2.21$2.28$2.29$1.49
Diluted weighted average shares358M361M361M363M364M365M364M362M360M360M357M352M
Basic weighted average shares352M354M355M356M356M358M359M357M355M355M354M349M
EBITDA$573.4M$578.7M$679.1M$693.5M$859.6M$727.7M$907.8M$929.3M$1.06B$1.06B$1.20B$805.5M
EBITDA margin29.7%30.6%33.8%34.0%35.6%32.3%37.2%37.1%36.9%38.1%41.6%26.4%
Depreciation & amortization$123.2M$109.3M$111.8M$116.2M$124.7M$149.6M$164.4M$169.6M$193.5M$200.0M$231.1M$212.9M
Stock-based compensation$150.4M$153.3M$173.6M$172.9M$177.0M$185.2M$196.2M$203.5M$203.3M$209.5M$209.9M$212.6M

The main figures as JSON and plain text. See data and methodology.

ISRG in the terminal

Every line back twenty years, charts of any figure, segments and KPIs by quarter, valuation and alerts.